Vnitr Lek 2015, 61(12):1004-1005
ST2 a srdeční selhání: pouze další marker z rodiny nebo přeci jen něco více? - editorial
- I. interní kardioangiologická klinika LF UK a FN Hradec Králové, přednosta doc. MUDr. Josef Šťásek, Ph.D.
Received: September 20, 2015; Published: December 1, 2015 Show citation
References
- Velde AR, Meijers WC, de Boer RA. Biomarkers for risk prediction in acute decompensated heart failure. Curr Heart Fail Rep 2014; 11(3): 246-259.
Go to original source...
Go to PubMed...
- Griffiths HR, Augustyniak EM, Bennett SJ et al. Novel ageing-biomarker discovery using data-intensive technologies. Mech Ageing Dev 2015; 151: 114-121.
Go to original source...
Go to PubMed...
- Demyanetsa S, Kauna C, Pentza R et al. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J Mol Cell Cardiol 2013; 60: 16-26. Dostupné z DOI: <http://doi:10.1016/j.yjmcc.2013.03.020>.
Go to original source...
Go to PubMed...
- Januzzi JL, Mebazaa A, Di Somma S. ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel. Am J Cardiol 2015; 115(7 Suppl B): 26B-31B.
Go to original source...
Go to PubMed...
- Bayes-Genis A, Richards AM, Maisel AS et al. Multimarker testing with ST2 in chronic heart failure. Am J Cardiol 2015; 115(7 Suppl B): 76B-80B.
Go to original source...
Go to PubMed...